These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 19210165)

  • 1. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
    Sisowath C; Petersen I; Veiga MI; Mårtensson A; Premji Z; Björkman A; Fidock DA; Gil JP
    J Infect Dis; 2009 Mar; 199(5):750-7. PubMed ID: 19210165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
    Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
    Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
    Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of
    Maiga H; Grivoyannis A; Sagara I; Traore K; Traore OB; Tolo Y; Traore A; Bamadio A; Traore ZI; Sanogo K; Doumbo OK; Plowe CV; Djimde AA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.
    Achieng AO; Muiruri P; Ingasia LA; Opot BH; Juma DW; Yeda R; Ngalah BS; Ogutu BR; Andagalu B; Akala HM; Kamau E
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):92-9. PubMed ID: 26236581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained
    Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.
    Malmberg M; Ngasala B; Ferreira PE; Larsson E; Jovel I; Hjalmarsson A; Petzold M; Premji Z; Gil JP; Björkman A; Mårtensson A
    Malar J; 2013 Mar; 12():103. PubMed ID: 23506218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.
    Baraka V; Tinto H; Valea I; Fitzhenry R; Delgado-Ratto C; Mbonye MK; Van Overmeir C; Rosanas-Urgell A; Van Geertruyden JP; D'Alessandro U; Erhart A
    Antimicrob Agents Chemother; 2015 Jan; 59(1):734-7. PubMed ID: 25403659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
    Saha P; Guha SK; Das S; Mullick S; Ganguly S; Biswas A; Bera DK; Chattopadhyay G; Das M; Kundu PK; Ray K; Maji AK
    Antimicrob Agents Chemother; 2012 May; 56(5):2511-7. PubMed ID: 22314538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.
    Sondo P; Derra K; Diallo Nakanabo S; Tarnagda Z; Kazienga A; Zampa O; Valéa I; Sorgho H; Owusu-Dabo E; Ouédraogo JB; Guiguemdé TR; Tinto H
    PLoS One; 2016; 11(3):e0151565. PubMed ID: 27031231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
    Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
    PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.
    Balikagala B; Mita T; Ikeda M; Sakurai M; Yatsushiro S; Takahashi N; Tachibana SI; Auma M; Ntege EH; Ito D; Takashima E; Palacpac NM; Egwang TG; Onen JO; Kataoka M; Kimura E; Horii T; Tsuboi T
    Malar J; 2017 Jan; 16(1):23. PubMed ID: 28068997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
    Ursing J; Kofoed PE; Rodrigues A; Blessborn D; Thoft-Nielsen R; Björkman A; Rombo L
    J Infect Dis; 2011 Jan; 203(1):109-16. PubMed ID: 21148503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
    Adeel AA; Elnour FA; Elmardi KA; Abd-Elmajid MB; Elhelo MM; Ali MS; Adam MA; Atta H; Zamani G; Warsame M; Barrette A; Mohammady HE; Nada RA
    Malar J; 2016 May; 15(1):285. PubMed ID: 27209063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
    Dahlström S; Aubouy A; Maïga-Ascofaré O; Faucher JF; Wakpo A; Ezinmègnon S; Massougbodji A; Houzé P; Kendjo E; Deloron P; Le Bras J; Houzé S
    Antimicrob Agents Chemother; 2014; 58(1):1-10. PubMed ID: 24100489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands.
    Gresty KJ; Gray KA; Bobogare A; Taleo G; Hii J; Wini L; Cheng Q; Waters NC
    Malar J; 2014 Oct; 13():406. PubMed ID: 25318907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.
    Mbogo GW; Nankoberanyi S; Tukwasibwe S; Baliraine FN; Nsobya SL; Conrad MD; Arinaitwe E; Kamya M; Tappero J; Staedke SG; Dorsey G; Greenhouse B; Rosenthal PJ
    Am J Trop Med Hyg; 2014 Jul; 91(1):54-61. PubMed ID: 24799371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.
    Thomsen TT; Madsen LB; Hansson HH; Tomás EV; Charlwood D; Bygbjerg IC; Alifrangis M
    Am J Trop Med Hyg; 2013 Mar; 88(3):536-41. PubMed ID: 23382159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.